| Literature DB >> 34288559 |
Paul J White1, Elizabeth A Davis2, Marina Santiago3, Tom Angelo4, Alison Shield5, Anna-Marie Babey6, Barbara Kemp-Harper2, Gregg Maynard7, Hesham S Al-Sallami8, Ian F Musgrave9, Lynette B Fernandes10, Suong N T Ngo11, Tina Hinton12.
Abstract
Pharmacology education currently lacks an agreed knowledge curriculum. Evidence from physics and biology education indicates that core concepts are useful and effective structures around which such a curriculum can be designed to facilitate student learning. Building on previous work, we developed a novel, criterion-based method to identify the core concepts of pharmacology education. Five novel criteria were developed, based on a literature search, to separate core concepts in pharmacology from topics and facts. Core concepts were agreed to be big ideas, enduring, difficult, applicable across contexts, and useful to solve problems. An exploratory survey of 33 pharmacology educators from Australia and New Zealand produced 109 terms, which were reduced to a working list of 26 concepts during an online workshop. Next, an expert group of 12 educators refined the working list to 19 concepts, by applying the five criteria and consolidating synonyms, and added three additional concepts that emerged during discussions. A confirmatory survey of a larger group resulted in 17 core concepts of pharmacology education. This list may be useful for educators to evaluate existing curricula, design new curricula, and to inform the development of a concept inventory to test attainment of the core concepts in pharmacology.Entities:
Keywords: concept inventory; core concept; pharmacology education; postgraduate education; undergraduate education
Mesh:
Year: 2021 PMID: 34288559 PMCID: PMC8292785 DOI: 10.1002/prp2.836
Source DB: PubMed Journal: Pharmacol Res Perspect ISSN: 2052-1707
FIGURE 1Study design and description of the five stages used
Concept extraction outcomes from the ASCEPT workshop, CC‐PEG and confirmatory survey
| Concepts Extracted by Workshop groups (23, groups of 4–6) | Concepts extracted by Expert group (12) | Concepts from confirmatory survey (30) | ||
|---|---|---|---|---|
| 1. Mechanism of drug action | Round one (extraction) | Round two (rating using criteria) | Round 3 (ranked most to least important) | Confirmatory survey |
| 2. How the body handles a drug | 1. Drug absorption | 1. Drug absorption | 1. Concentration response relationships | 1. Concentration–response relationships 100% |
| 3. Drug safety | 2. Concentration response relationships | 2. Concentration response relationships | 2. Drug selectivity | 2. Drug efficacy 100% |
| 4. Medicines as therapeutics | 3. Drugs and homeostasis | 3. Drugs and homeostasis | 3. Drug efficacy | 3. Drug target 100% |
| 5. Quantification of dose response | 4. Drug excretion | 4. Drug excretion | 4. Drug affinity | 4. Drug absorption 100% |
| 6. Drug discovery & development | 5. Drugs and complex systems | 5. Drugs and complex systems | 5. Mechanism of drug action | 5. Drug tolerance 100% |
| 7. Concentration response relationships | 6. Drug distribution | 6. Drug distribution | 6. Drug target | 6. Drug distribution 100% |
| 8. Drug selectivity and specificity | 7. Drug interactions | 7. Drug safety/adverse drug reactions | 7. Drug distribution | 7. Individual variation 100% |
| 9. Concentration occupancy relationships | 8. Drug target | 8. Drug target | 8. Drug safety | 8. Drug selectivity 96% |
| 10. Sites of drug action | 9. Drug metabolism | 9. Drug metabolism | 9. Drug metabolism | 9. Bioavailability 96% |
| 11. Absorption | 10. Mechanism of drug action | 10. Mechanism of drug action | 10. Drug absorption | 10. Drug safety 96% |
| 12. Distribution | 11. Drug efficacy | 11. Drug efficacy | 11. Individual variation | 11. Drug potency 96% |
| 13 Metabolism | 12. Drug selectivity and specificity | 12. Drug selectivity and specificity | 12. Drugs and homeostasis | 12. Drug metabolism 96% |
| 14 Excretion | 13. Drug affinity | 13. Drug affinity | 13. Drug excretion | 13. Mechanism of drug action 92% |
| 15. How are drugs handled by the body? | 14. Statistical significance | 14. Drug tolerance | 14. Bioavailability | 14. Therapeutic window 92% |
| 16. Drug–receptor interactions | 15. Individual variation | 15. Individual variation | 15. Drug tolerance | 15. Drug excretion 92% |
| 17. Drugs treating complex system | 16. Bioavailability | 16. Drugs and complex systems | 16. Drug affinity 92% | |
| 18. Metabolism | 17. Drug elimination | 17. Drug elimination 91% | ||
| 19. Dose matters | 18. Therapeutic window | Below 80% agreement | ||
| 20. Individual variation | 19. Drug potency | 18. Drugs and complex systems 79% | ||
| 21. Drug efficacy | 19. Drugs and homeostasis 76% | |||
| 22. Selectivity | ||||
| 23. ADME | ||||
| 24. What the drug does to the body | ||||
| 25. What the body does to the drug | ||||
| 26. Drug–drug interactions | ||||
The first column shows the concepts that the workshop groups extracted during the workshop, and the next three columns show the concepts that emerged from the three rounds of CC‐PEG extraction and refinement. The final column shows each concept from the confirmatory survey with the % agreement for inclusion of each concept as a core concept of pharmacology education.
Criterion‐based evaluation of the concepts by (i) CC‐PEG concept extraction (EG) and (ii) confirmatory survey participants (CS)
| Concept | Useful to solve/predict | Big idea | Enduring idea | Applies to multiple contexts | Difficult for students | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| EG | CS | EG | CS | EG | CS | EG | CS | EG | CS | |
|
1. Drug absorption | 90 | 76 | 70 | 44 | 90 | 64 | 100 | 80 | 70 | 12 |
| 2. Concentration response relationships | 90 | 92 | 100 | 56 | 100 | 76 | 100 | 92 | 70 | 40 |
| 3. Drugs and homeostasis | 70 | 68 | 90 | 52 | 100 | 52 | 100 | 64 | 90 | 48 |
| 4. Drug excretion | 100 | 81 | 60 | 50 | 90 | 69 | 100 | 69 | 40 | 19 |
| 5. Drugs and complex systems | 60 | 66 | 80 | 75 | 90 | 58 | 100 | 79 | 90 | 66 |
| 6. Drug distribution | 80 | 84 | 70 | 52 | 90 | 64 | 100 | 76 | 70 | 48 |
| 7. Drug safety | 100 | 76 | 100 | 72 | 100 | 64 | 100 | 84 | 80 | 40 |
| 8. Drug target | 90 | 83 | 80 | 71 | 90 | 79 | 100 | 96 | 60 | 17 |
| 9. Drug metabolism | 90 | 92 | 80 | 72 | 90 | 72 | 100 | 90 | 80 | 24 |
| 10. Mechanism of drug action | 100 | 84 | 90 | 68 | 100 | 60 | 100 | 88 | 80 | 36 |
| 11. Drug efficacy | 90 | 80 | 80 | 72 | 90 | 76 | 100 | 76 | 80 | 56 |
| 12. Drug selectivity | 100 | 80 | 80 | 40 | 90 | 64 | 100 | 84 | 90 | 56 |
| 13. Drug affinity | 100 | 67 | 70 | 50 | 90 | 75 | 100 | 75 | 70 | 29 |
| 14.Drug tolerance | 100 | 72 | 70 | 48 | 90 | 52 | 100 | 76 | 90 | 60 |
| 15. Individual variation | 100 | 80 | 90 | 76 | 100 | 56 | 100 | 72 | 80 | 52 |
| 16. Bioavailability | 90 | 84 | 50 | 50 | 100 | 60 | 100 | 80 | 70 | 36 |
| 17. Drug potency | 91 | 80 | 73 | 52 | 82 | 68 | 91 | 80 | 73 | 50 |
| 18. Therapeutic window | 91 | 80 | 91 | 52 | 100 | 64 | 100 | 68 | 55 | 20 |
| 19. Drug elimination | 100 | 91 | 91 | 61 | 100 | 61 | 91 | 70 | 91 | 26 |
| Means | 91 | 80 | 80 | 59 | 94 | 65 | 94 | 79 | 75 | 39 |
The data provided indicates the percentage of CC‐PEG members who agreed that the concept met each criterion. Ten of the 12 CC‐PEG members completed Round two, and 30 respondents completed the confirmatory survey.
FIGURE 2Ratings of core concepts by basic science and clinical educators using five criteria. Data are percent agreement for each group of educators for all 19 proposed concepts combined. * indicate a significant difference from the basic science educator agreement (ANOVA, p < .05)
FIGURE 3A diagrammatic representation of the final list of concepts produced by the CC‐PEG